Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5

This publication has 51 references indexed in Scilit:

• REGULATION OF APO-2 LIGAND/TRAIL EXPRESSION IN NK CELLS—INVOLVEMENT IN NK CELL-MEDIATED CYTOTOXICITY
  Cytokine, 1999
• Safety and antitumor activity of recombinant soluble Apo2 ligand
  Journal of Clinical Investigation, 1999
• Inherited Human Caspase 10 Mutations Underlie Defective Lymphocyte and Dendritic Cell Apoptosis in Autoimmune Lymphoproliferative Syndrome Type II
  Cell, 1999
• Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAIL
  The Journal of Experimental Medicine, 1999
• TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
  Annual Review of Immunology, 1999
• The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain
  Immunity, 1997
• KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene
  Nature Genetics, 1997
• Apoptosis by Death Factor
  Cell, 1997
• Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
  Journal of Biological Chemistry, 1996
• Identification and characterization of a new member of the TNF family that induces apoptosis
  Immunity, 1995